Efmitermant alfa Uses, Dosage, Side Effects and more
Efmitermant alfa, a locally-acting GDF/activin ligand trap, is under investigation in clinical trial NCT03124459 (Study of ACE-083 in Patients With Charcot-marie-tooth Disease).
| Attribute | Details |
|---|---|
| Trade Name | Efmitermant alfa |
| Generic | Efmitermant alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
